Polycythemia as a Complication of Long-acting Injectable Testosterone Undecanoate.
- Author:
Dong Sik SHIN
1
;
Ki Won KO
;
Sang Gan NAM
;
Myeong Heon JIN
;
Je Jong KIM
;
Du Geon MOON
Author Information
1. Department of Urology, Korea University College of Medicine, Seoul, Korea. dgmoon@korea.ac.kr
- Publication Type:Case Report
- Keywords:
Erythrocytosis;
Polycythemia;
Testosterone
- MeSH:
Anoxia;
Erythrocyte Count;
Erythropoiesis;
Erythropoietin;
Humans;
Middle Aged;
Polycythemia;
Testosterone
- From:Korean Journal of Andrology
2008;26(4):237-239
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Polycythemia is a condition in which the red blood cell count is increased due to an inherited or acquired mutation, a physiologic response to hypoxia, autonomous erythropoietin production, or deliberate erythropoietin administration. Higher testosterone levels appear to act as a stimulus for erythropoiesis and testosterone replacement therapies have rarely been reported as causes of polycythemia. We report here a case of a 51-year-old man with polycythemia that was caused by long-acting testosterone undecanoate (Nebido(R)).
